SciTransfer
Organization

IP HEALTH SOLUTIONS BV

Dutch health IT SME building patient self-management tools, activity monitoring, and decision support for chronic care and active aging.

Technology SMEhealthNLSMENo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
€285K
Unique partners
25
What they do

Their core work

IP Health Solutions is a Dutch health technology SME that develops digital tools for patient empowerment and self-management, with a particular focus on people living with chronic conditions and older adults. Their work sits at the intersection of activity monitoring, clinical decision support, and connected care — building patient-facing technology that puts individuals in control of their own health data and care plans. In EU research consortia, they contribute a commercial health IT perspective to projects exploring 4P medicine principles: care that is predictive, preventive, personalized, and participatory. Based in Groningen, they operate close to one of the Netherlands' leading academic medical centres, which likely shapes their clinically grounded approach.

Core expertise

What they specialise in

Patient self-management systemsprimary
2 projects

Both my-AHA and CONNECARE centred on enabling patients to actively manage their own health, with CONNECARE explicitly listing self-management as a core keyword.

Activity monitoring for healthprimary
2 projects

Activity monitoring is a named keyword in CONNECARE, and my-AHA's focus on active healthy aging implies physical activity tracking as a core component.

1 project

Decision support systems is an explicit keyword from CONNECARE, suggesting IP Health Solutions contributes to tools that help clinicians or patients make informed care decisions.

Connected care for chronic patientssecondary
1 project

CONNECARE (Personalised Connected Care for Complex Chronic Patients) directly addresses remote, digitally connected care management for people with multiple chronic conditions.

4P medicine and personalised healthemerging
1 project

4P medicine — predictive, preventive, personalized, participatory — appears as a keyword in CONNECARE, indicating alignment with a forward-looking model of care delivery.

Evolution & trajectory

How they've shifted over time

Early focus
Active and healthy aging
Recent focus
Chronic care self-management, 4P medicine

Both H2020 projects launched in the same year (2016), which limits meaningful longitudinal analysis — there is no earlier versus later phase in the conventional sense. What the data does show is a thematic sharpening: my-AHA addressed broad active and healthy aging without recorded keywords, while CONNECARE introduced a precise clinical vocabulary — 4P medicine, decision support, self-management — suggesting IP Health Solutions refined their positioning toward chronic disease management and personalised care during overlapping project work. If there is a trajectory here, it runs from general wellness technology toward structured, evidence-based chronic care tools with a stronger clinical decision-support component.

IP Health Solutions appears to be moving from broad wellness and aging toward clinically grounded chronic disease management, where patient empowerment tools are tied to structured decision support — a commercially more defensible position.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European11 countries collaborated

IP Health Solutions has participated exclusively as a consortium partner across both projects, never taking on a coordination role. Despite only two projects, they engaged with 25 unique partners across 11 countries, which points to participation in large, multi-institutional consortia rather than small focused teams. This profile suggests a company that contributes specialist health technology expertise within bigger research programmes, comfortable operating as one of many partners rather than as the driving force.

With 25 unique consortium partners spread across 11 countries from just two projects, IP Health Solutions has an unusually broad network relative to their project volume — each project they joined was a large pan-European collaboration. Their network reflects the wide geography of EU health research rather than a tightly knit regional cluster.

Why partner with them

What sets them apart

Among Dutch health technology SMEs, IP Health Solutions occupies a specific niche: patient-facing digital tools anchored in 4P medicine and chronic care self-management, rather than hospital infrastructure or diagnostic equipment. Their simultaneous involvement in both a healthy aging project and a complex chronic care project shows they can serve two different but related patient populations — older adults and people with long-term conditions — with overlapping technology. For consortium builders, they bring a commercial SME lens to research partnerships that often skew heavily academic, which can strengthen exploitation and impact plans.

Notable projects

Highlights from their portfolio

  • my-AHA
    The largest single funding award for IP Health Solutions (EUR 151,396) and the longest-running project (2016–2020), addressing active and healthy aging — a high-priority EU public health challenge.
  • CONNECARE
    The richest source of IP Health Solutions' technical identity, explicitly linking them to 4P medicine, patient empowerment, decision support systems, and connected chronic care — the clearest signal of what they actually build.
Cross-sector capabilities
Digital health data platforms and analyticsAssistive technology for aging populationsBehavioural monitoring and lifestyle data
Analysis note: Profile is based on only 2 projects, both starting in the same year (2016), which prevents meaningful longitudinal analysis. No website was available for independent verification of their current products or market focus. One project (my-AHA) yielded no keywords, limiting the technical depth of the analysis. The 'IP' in the company name may suggest an intellectual property or licensing model, but this cannot be confirmed from project data alone. Treat all characterisations as indicative rather than definitive.